(The following press release from Bayer was received by e-mail. It was not
confirmed by the sender.)
Dear Newsletter Subscriber,
The following news item has been released:
Increasing demand for innovative and sustainable agricultural solutions
Bayer CropScience steps up investment plans: EUR 2.4 billion earmarked for
capacity expansion between 2013 and 2016
Production of key active ingredients to increase substantially / On track
to grow sales towards EUR 10 billion in 2015
Monheim, September 5, 2013 - Bayer CropScience is on track to grow annual
sales towards EUR 9 billion in 2013 and towards EUR 10 billion in 2015.
"Since 2007 we have continuously expanded our business with record sales,
and we are optimistic about the future development," said Bayer CropScience
CEO Liam Condon at the company’s annual press conference in Monheim,
Germany. Against the background of strong demand for its products, the
company is adding EUR 1 billion to its investment program, bringing total
capital expenditures for the period 2013 to 2016 to approximately EUR 2.4
As a result of the accelerated investment program, the production volume of
key active ingredients for crop protection products is expected to increase
significantly. "Many industries today are facing overproduction. At Bayer
CropScience, we are in a completely different situation: A growing global
population, changing diets and increasing weather volatility are affecting
food supply and need to be addressed today," said Condon.
"Demand from farmers for our products is increasing so strongly that we’re
significantly stepping up our supply chain capacity to serve farmers around
the world with much needed innovative agricultural solutions," added Liam
Condon, describing the challenge: "About 900 million people remain hungry
today and the world population is growing strongly. We need to raise
agricultural productivity and at the same time advance sustainability in
farming and ensure protection of the environment. We aim to achieve this by
developing innovative solutions and services that can help agriculture to
contribute to the healthy development of society."
About EUR 380 million investment in new glufosinate-ammonium plant in the
One integral element of Bayer CropScience’s investment plans is the
construction of a new plant in Mobile/Alabama for the production of the
herbicide glufosinate-ammonium, marketed in the United States under the
brand name Liberty™. The start-up of the new plant is anticipated probably
for the fourth quarter of 2015, in time for the 2016 growing season. "With
about EUR 380 million earmarked for this new facility, this is the biggest
single construction project in the history of Bayer CropScience," said
Condon. Along with capacity expansion projects currently under way at other
sites, this new facility will contribute significantly to the company’s
target of more than doubling global product supply for this important
The increased production of Liberty™ will help to fight weed resistance, a
key challenge for modern agriculture. Liberty™ is the only non-selective
herbicide that controls weeds resistant to the most used herbicide,
glyphosate. About 50 percent of the farmers in the USA have experienced
weed resistance on their fields, and the situation is worsening further not
only in the United States but also around the world.
Bayer CropScience is addressing this problem with its unique expertise in
R&D, the most diverse herbicide portfolio in the industry, diagnostics and
monitoring, and by promoting an Integrated Weed Management (IWM) approach.
IWM techniques such as crop rotation, the use of herbicides with different
modes of action - glufosinate-ammonium being one of the cornerstones - and
rotation of herbicide-tolerant traits help growers to manage or delay weed
resistance, as no single strategy will be completely effective on its own.
"Diversity is the key to sustainable agriculture," stressed Condon.
Expanding the Seeds business - building up strong positions in soybean and
In addition to the ramp-up of its supply chain capacity in Crop Protection,
another element of the company’s growth plan is the implementation of its
Seeds strategy. Bayer CropScience plans to further strengthen its position
in established crops such as vegetables, rice, oilseed rape and cotton, and
to build up significant market positions in soybean and wheat.
"We are continuing to invest in our soybean business, for example through
strategic acquisitions in Latin America, contributing to a fast and focused
development of distinctive traits," explained Condon, who highlighted the
soybean cyst nematode trait currently under development at Bayer
CropScience. He also announced the planned launch of the global Bayer
CropScience soybean brand Credenz™ for late 2014 in North and South
America. "Credenz™ soybean seeds will help us to deliver improved varieties
to growers. It will offer future traits that could protect soybeans against
specific insects, repel persistent attacks by nematodes, and make soybeans
tolerant to the most effective herbicides," said Condon. The company
intends to significantly expand today’s soybean-related sales within the
A second seed investment focus for the company is wheat, the world’s most
important staple crop. Here, Bayer CropScience is building a leading global
wheat breeding network, with the objective of developing high-yielding
varieties adapted to local growing conditions. First varieties are expected
to come to market in 2015.
"Our business strategy is aimed at addressing the pressing challenges
farmers are facing worldwide," concluded Condon. "We will further
strengthen both our CropProtection and our Seeds businesses, continue to
sharpen our customer focus and foster innovation to strengthen our leading
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health
care, agriculture and high-tech materials. This year the company looks back
on 150 years of working to fulfill its mission "Bayer: Science For A Better
Life". Bayer CropScience, the subgroup of Bayer AG responsible for the
agricultural business, has annual sales of EUR 8,383 million (2012) and is
one of the world’s leading innovative crop science companies in the areas
of seeds, crop protection and non-agricultural pest control. The company
offers an outstanding range of products including high value seeds,
innovative crop protection solutions based on chemical and biological modes
of action as well as an extensive service backup for modern, sustainable
agriculture. In the area of non-agricultural applications, Bayer
CropScience has a broad portfolio of products and services to control pests
from home and garden to forestry applications. The company has a global
workforce of 20,800 and is represented in more than 120 countries. This
and further news is available at: http://www.press.bayercropscience.com.
Find more information at http://www.bayercropscience.com.
Social Media Kit: @Bayer4Crops, @facebook.com/bayercropscience, @slideshare
to view presentation slides, @Flickr photos of event,
@YouTube.com/bayercropscience video highlights
This release may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management.
Various known and unknown risks, uncertainties and other factors could lead
to material differences between the actual future results, financial
situation, development or performance of the company and the estimates
given here. These factors include those discussed in Bayer’s public reports
which are available on the Bayer website at http://www.bayer.com. The
company assumes no liability whatsoever to update these forward-looking
statements or to conform them to future events or developments.
This press release is available here:
Yours BayNews Editorial Team
51368 Leverkusen, Germany
Further news releases you can find here: http://www.press.bayer.com
N.B. This is an automatically generated e-mail which you cannot reply to.
If you have any questions, please send us an e-mail via our contact form:
You can cancel your subscription to the BayNews-Newsletter or change your
personal settings at any time by going to
To ensure receipt, please add email@example.com to your
address book or list of trusted senders.
© Bayer AG, 51368 Leverkusen, Germany.
All rights reserved. The entire contents, including images, graphics,
animations etc., of this e-mail and the server http://www.bayer.com are
Board of Management: Marijn Dekkers, Chairman | Werner Baumann, Michael
König, Wolfgang Plischke
Chairman of the Supervisory Board: Werner Wenning
Registered office: Leverkusen | Local Court of Cologne, HRB 48248
Press spacebar to pause and continue. Press esc to stop.